Reuters logo
BRIEF-Sorrento Therapeutics to contribute immuno-oncology and cellular therapy intellectual property, assets to Celularity
June 13, 2017 / 1:15 PM / 5 months ago

BRIEF-Sorrento Therapeutics to contribute immuno-oncology and cellular therapy intellectual property, assets to Celularity

June 13 (Reuters) - Sorrento Therapeutics Inc-

* Sorrento Therapeutics - co, unit executed definitive agreement to contribute certain immuno-oncology and cellular therapy intellectual property, assets to Celularity Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below